CG
ARDS

Cutler Group’s Aridis Pharmaceuticals Inc. Common Stock ARDS Stock Holding History

Cutler Group’s Portfolio ARDS Stock Details ARDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,100
Closed -$1K – 6318
2021
Q4 		$1K Buy
+4,100
New +$11.7K ﹤0.01% 5247

Other funds holding ARDS

Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cutler Group's ARDS Position: Q3 2022 in Review

Cutler Group sold out of Aridis Pharmaceuticals Inc. Common Stock (ARDS) in Q3 2022, closing a stake of 1,342 shares — an estimated $1K sold.

Cutler Group first reported a position in ARDS in Q4 2021 and held it in 3 quarters. The position peaked at $2K in Q1 2022. 16 funds tracked by Wall St. Rank hold ARDS as of Q3 2022.

  • Cutler Group reported no remaining Aridis Pharmaceuticals Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Cutler Group sold 1,342 Aridis Pharmaceuticals Inc. Common Stock shares in Q3 2022, an estimated $1K.
  • Cutler Group first reported a position in Aridis Pharmaceuticals Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • Cutler Group's Aridis Pharmaceuticals Inc. Common Stock position peaked at $2K in Q1 2022.
  • 16 funds tracked by Wall St. Rank held Aridis Pharmaceuticals Inc. Common Stock as of Q3 2022.

Based on Cutler Group's 13F filing for Q3 2022, filed 25 Oct 2022.